Short Interest in Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Drops By 78.8%

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 19,501 shares, a decline of 78.8% from the June 15th total of 91,883 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Shin Nippon Biomedical Laboratories Stock Performance

SBLOF stock remained flat at $7.00 on Monday. The stock has a 50 day moving average price of $8.12 and a two-hundred day moving average price of $9.21. Shin Nippon Biomedical Laboratories has a fifty-two week low of $7.00 and a fifty-two week high of $9.16.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.